[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337444-105":59,"doc-detail-337444-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-rna-m6a-writer-mettl3-in-tumor-microenvironment-emerging-roles-and-therapeutic-implications","The RNA m6A writer METTL3 in tumor microenvironment - emerging roles and therapeutic implications","","The tumor microenvironment (TME) is a heterogeneous ecosystem of cancer cells, immune cells, stromal elements, and non-cellular components that collectively shape tumor progression and responsiveness to immunotherapy. METTL3, a central N6-methyladenosine (m6A) writer, is linked to dysregulation of the m6A epitranscriptome across multiple cancers, influencing both malignant cells and surrounding TME. This review systematically summarizes METTL3 functions in TME, emphasizes effects on tumor-infiltrating immune cells, details m6A-dependent mechanisms, and discusses current efforts to develop METTL3 inhibitors to enhance immunotherapy efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-rna-m6a-writer-mettl3-in-tumor-microenvironment-emerging-roles-and-therapeutic-implications/337444/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-rna-m6a-writer-mettl3-in-tumor-microenvironment-emerging-roles-and-therapeutic-implications/337444.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles does METTL3 play in the tumor microenvironment?","Question",{"text":112,"@type":113},"METTL3 is frequently associated with abnormalities in the m6A epitranscriptome and can influence both cancer cells and components of the TME, including immune and stromal contexts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does m6A modification relate to RNA regulation in cancer and immunity?",{"text":117,"@type":113},"m6A is dynamically regulated by m6A writers and erasers, and through m6A-binding proteins it affects key RNA processes such as decay, translation, export, stability, and microRNA processing.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are METTL3 inhibitors considered for cancer immunotherapy?",{"text":121,"@type":113},"Targeting METTL3 may reprogram the TME and potentially restore or enhance anti-cancer immune responses, thereby improving the effectiveness of immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337444,1790560892,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Review  \nPUBLISHED 22 January 2024  \nDOI 10.3389/fimmu.2024.1335774  \nOPEN ACCESS  \nEDITED BY  \nChengwu Zeng, Jinan University, China  \nREVIEWED BY Di Chen,  \nZhejiang University, China Kai Song,  \nUniversity of California, Los Angeles, United States  \nChen Xue,  \nZhejiang University, China  \n*CORRESPONDENCE Wenting Liao  \n [liaowt@sysucc.org.cn](liaowt@sysucc.org.cn)[ ](liaowt@sysucc.org.cn)Huilin Huang  \n [huanghl1@sysucc.org.cn](huanghl1@sysucc.org.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 09 November 2023  \nACCEPTED 04 January 2024  \nPUBLISHED 22 January 2024  \nCITATION  \nSu W, Che L, Liao W and Huang H (2024) The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications.  \nFront. Immunol. 15:1335774 .  \ndoi: 10.3389/fimmu.2024.1335774  \nCOPYRIGHT  \n© 2024 Su, Che, Liao and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe RNA m 6A writer METTL3 in tumor microenvironment:  \nemerging roles and therapeutic implications  \nWeiqi Su †, Lin Che †, Wenting Liao* and Huilin Huang*  \nState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China  \nThe tumor microenvironment (TME) is a heterogeneous ecosystem comprising cancer cells, immune cells, stromal cells, and various non-cellular components, all of which play critical roles in controlling tumor progression and response to immunotherapies. Methyltransferase-like 3 (METTL3), the core component of N6-methyladenosine (m6A) writer, is frequently associated with abnormalities in the m6A epitranscriptome in different cancer types, impacting both cancer cells and the surrounding TME. While the impact of METTL3 on cancer cells has been extensively reviewed, its roles in TME and anti-cancer immunity have not been comprehensively summarized. This review aims to systematically summarize the functions of METTL3 in TME, particularly its effects on tumor-inﬁltrating immune cells . We also elaborate on the underlying m6A-dependent mechanism. Additionally, we discuss ongoing endeavors towards developing METTL3 inhibitors, as well as the potential of targeting METTL3 to bolster the efﬁcacy of immunotherapy.  \nKEYWORDS  \nmethyltransferase-like 3 (METTL3), N6-methyladenosine (m6A), tumor-inﬁltrating immune cells (TICs), small molecular inhibitors, cancer immunotherapy, immune checkpoint inhibitors (ICI)  \n1 Introduction  \nTumor is a complicated ecosystem that is composed of cancer cells, various nonneoplastic cell components and extracellular matrix (1) . The cellular and non-cellular components surrounding cancer cells form the tumor microenvironment (TME), which consists of (i) immune cells such as tumor-associated macrophages (TAMs), myeloidderived suppressor cells (MDSCs), natural killer cells (NKs), neutrophils, dendritic cells (DCs), T cells, and B cells; (ii) stromal cells such as cancer-associated ﬁbroblasts (CAFs) and vascular endothelial cells (VECs); and (iii) extracellular matrix such as extracellular vesicles (EVs) (Figure 1) . It is acknowledged that TME plays critical roles  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nSu et al. 10.3389/fimmu.2024.1335774  \nFIGURE 1  \nThe composition of tumor microenvironment. TAMs, tumor-associated macrophages; MDSCs, myeloid-derived suppressor cells; NKs, natural killer cells; DCs, Dendritic cells; CAFs, cancer-associated ﬁbroblasts; VECs, vascular endothelial cells; EVs, extracellular vesicles.  \nthroughout the development and progression of tumors . Speci","cbCaicsCEAlxLeiP","https://ap.wps.com/l/cbCaicsCEAlxLeiP","pdf",1879084,11,"English","# Introduction\n## Composition and dual roles of the tumor microenvironment\n## Epitranscriptomic dysregulation and immune evasion\n## Overview of m6A writers and regulators\n## METTL3 as the catalytic component of the m6A methyltransferase complex","[{\"question\":\"What roles does METTL3 play in the tumor microenvironment?\",\"answer\":\"METTL3 is frequently associated with abnormalities in the m6A epitranscriptome and can influence both cancer cells and components of the TME, including immune and stromal contexts.\"},{\"question\":\"How does m6A modification relate to RNA regulation in cancer and immunity?\",\"answer\":\"m6A is dynamically regulated by m6A writers and erasers, and through m6A-binding proteins it affects key RNA processes such as decay, translation, export, stability, and microRNA processing.\"},{\"question\":\"Why are METTL3 inhibitors considered for cancer immunotherapy?\",\"answer\":\"Targeting METTL3 may reprogram the TME and potentially restore or enhance anti-cancer immune responses, thereby improving the effectiveness of immunotherapy.\"}]","The RNA m6A writer METTL3 in tumor microenvironment - emerging roles and therapeutic implications | PDF",1790019174,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2e077c81d547434753ab038bcdec695.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62ad0384a4a1fc8c7dcf4fc2042834cb.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47da7c7ba965970978c0874f307731d6.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c32ac0afd76b44384b32d4e6fb7b965.webp",980,1385]